Significantly higher faecal counts of the yeasts candida and saccharomyces identified in people with coeliac disease

Gut Pathogens

Volumn 9, Issue 1, 2017, Pages

  Harnett, Joanna ^a   Myers, Stephen P ^b   Rolfe, Margaret ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b SOUTHERN CROSS UNIVERSITY   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Candida; Coeliac disease; Microbiota; Saccharomyces; Yeasts

Indexed keywords

EID: 85018790590     PISSN: None     EISSN: 17574749     Source Type: Journal    
DOI: 10.1186/s13099-017-0173-1     Document Type: Article

References (38)

1. Green P, Jabri B. Celiac disease. Annu Rev Med. 2006;57:207-21.
2. Midhagen G, Hallert C. High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study. Am J Gastroenterol. 2003;98(9):2023-6.
3. Paarlahti P, et al. Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study. BMC Gastroenterol. 2013;13(1):75.
4. Verdu EF, Galipeau HJ, Jabri B. Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol. 2015;12(9):497-506.
5. Cani P, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470-81.
6. Kostic AD, Aleksandar D, et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell host microbe. 2015;17(2):260-73.
7. Sheehan D, Moran C, Shanahan F. The microbiota in inflammatory bowel disease. J Gastroenterol. 2015;50(5):495-507.
8. Brennan CA, Garrett WS. Gut microbiota, inflammation, and colorectal cancer. Annu Rev Microbiol. 2016;70(1):395-411.
9. Sanz Y, Palma GD, Laparra M. Unraveling the ties between celiac disease and intestinal microbiota. Int Rev Immunol. 2011;30(4):207-18.
10. Collado M, Calabuig M, Sanz Y. Differences between the fecal microbiota of coeliac infants and healthy controls. Curr Issues Intest Microbiol. 2007;8(1):9-14.
11. Collado MC, et al. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol. 2009;62(3):264-9.
12. De Palma G, et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 2010;10(1):63.
13. De Palma G, et al. Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study. PLoS ONE. 2012;7:e30791.
14. Nadal I, et al. Imbalance in the composition of the duodenal microbiota of children with celiac disease. J Med Microbiol. 2007;56:1669-74.
15. Sanchez E, et al. Reduced diversity and increased virulence-gene carriage in intestinal enterobacteria of coeliac children. BMC Gastroenterol. 2008;8(1):50.
16. Sanz Y, et al. Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis. FEMS Immunol Med Microbiol. 2007;51:562-8.
17. Wacklin P, et al. Altered duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a long-term gluten-free diet. Am J Gastroenterol. 2014;109(12):1933-41.
18. Harnett J, Myers SP, Rolfe M. Probiotics and the microbiome in celiac disease: a randomised controlled trial. Evid Based Complement Altern Med. 2016;2016:16.
19. Häuser W, et al. Development and validation of the Celiac Disease Questionnaire (CDQ), a disease-specific health-related quality of life measure for adult patients with celiac disease. J Clin Gastroenterol. 2007;41(2):157-66.
20. Scott DL, Bralley JA, George JM. Process and method for monitoring gastrointestinal microbiota. US patent 20120021921. 2012.
21. Mukherjee PK, et al. Mycobiota in gastrointestinal diseases. Nat Rev Gastroenterol Hepatol. 2015;12(2):77-87.
22. Yamaguchi N, et al. Gastrointestinal Candida colonisation promotes sensitisation against food antigens by affecting the mucosal barrier in mice. Gut. 2006;55(7):954-60.
23. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91(1):151-75.
24. Fasano A. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol. 2012;10(10):1096-100.
25. Corouge M, et al. Humoral immunity links Candida albicans infection and celiac disease. PLoS ONE. 2015;10(3):e0121776.
26. Nieuwenhuizen WF, et al. Is Candida albicans a trigger in the onset of coeliac disease? Lancet. 2003;361(9375):2152-4.
27. Cataldo F, et al. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Gut. 1998;42(3):362-5.
28. Ludvigsson JF, Neovius M, Hammarström L. Association between IgA deficiency & other autoimmune conditions: a population-based matched cohort study. J Clin Immunol. 2014;34(4):444-51.
29. Ludvigsson JF, Neovius M, Hammarström L. Risk of infections among 2100 individuals with IgA deficiency: a nationwide cohort study. J Clin Immunol. 2016;36(2):134-40.
30. Gerard R, et al. An immunological link between Candida albicans colonization and Crohn's disease. Crit Rev Microbiol. 2015;41(2):135-9.
31. Chehoud C, et al. Fungal Signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1948-56.
32. Jawhara S, et al. Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J Infect Dis. 2008;197(7):972-80.
33. Marra F, et al. Antibiotic use among children in British Columbia. Canada. J Antimicrob Chemother. 2006;58:830-9.
34. Mårild K, et al. Antibiotic exposure and the development of coeliac disease: a nationwide case-control study. BMC Gastroenterol. 2013;13(1):1-9.
35. Blandino A, et al. Cereal-based fermented foods and beverages. Food Res Int. 2003;36(6):527-43.
36. Mallant-Hent RC, et al. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Eur J Gastroenterol Hepatol. 2006;18(1):75-8.
37. Hempel S, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307(18):1959-69.
38. Hempel S, et al. Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess. 2011;200:1-645.